Prof. Yair Herishanu, MD, is a renowned hematologist-oncologist based in Tel Aviv, Israel, with a deep focus on blood cancers, particularly chronic lymphocytic leukemia (CLL). He currently serves at the prestigious Sourasky Medical Center (Ichilov) in Tel Aviv where he leads the Hematology Clinic and CLL Unit.
Full Name: Prof. Yair Herishanu, MD
Years of Experience: Over 20 years
Main Specialty: Hematology-Oncology with a focus on CLL
Current Hospital: Sourasky Medical Center (Ichilov), Israel
Educational Background
Prof. Herishanu received advanced medical education and training from top institutions in Israel and the United States, ensuring global standards in care.
Medical School: Ben-Gurion University of the Negev, Israel (1989–1995)
Residency in Internal Medicine: Rabin Medical Center (1997–1998)
Residency in Internal Medicine: Meir Medical Center (1998–2001)
Residency in Hematology: Tel Aviv Medical Center (2001–2004)
Fellowship: Hematology Branch, NIH, Bethesda, USA (2006–2008)
Prof. Herishanu has held prestigious roles in clinical hematology and is currently leading one of Israel’s top hematology units.
Current Position: Director, CLL Unit and Hematology Clinic, Tel Aviv Sourasky Medical Center (Ichilov)
Previous Roles: Senior Hematologist at Tel Aviv Medical Center
Academic Role: Associate Professor, Sackler Faculty of Medicine, Tel Aviv University
Academic Contributions
He is deeply involved in academic training and has contributed to clinical research and education in hematology.
Academic Title: Associate Professor of Hematology
University Affiliation: Sackler Faculty of Medicine, Tel Aviv University
Conference Speaker: Regular speaker at international forums on leukemia and lymphoma
Research Interests: CLL, B-cell signaling, targeted therapies
Areas of Expertise
Prof. Herishanu specializes in the diagnosis and treatment of complex blood-related diseases using advanced and personalized therapies.
Chronic lymphocytic leukemia (CLL): His main area of focus
Acute and chronic leukemias
Lymphomas: Both Hodgkin and non-Hodgkin types
Multiple myeloma
Autoimmune hemolytic anemia
Anemia and thrombocytopenia
Bleeding disorders: Including hemophilia
Publications and Research
Prof. Herishanu has published extensively in peer-reviewed journals, advancing the understanding of CLL and innovative treatments.
Front Immunol (2022): Explored B-cell receptor organization in CLL
Front Oncol (2021): Demonstrated how BTK-targeting PROTACs inhibit CLL cell signaling
J Am Chem Soc (2020): Presented innovative degradation strategies using reversible covalent PROTACs
His research supports the development of targeted treatments and novel therapeutics for CLL and related disorders.
Patient Care Philosophy
Prof. Herishanu is committed to providing empathetic, personalized care backed by the latest research. His approach focuses on building trust and tailoring treatments to each individual.
Patient-Centered Care: Every treatment plan is customized
Clear Communication: Ensures patients fully understand their diagnosis and therapy
International Access: Available for pre-consultation and follow-ups online
Languages: English, Hebrew; Russian available with interpreter
Professional Affiliations
Prof. Herishanu is part of leading national and international medical societies in hematology, reflecting his global influence in the field.
Israeli Hematology Association
American Society of Hematology (ASH)
European Research Initiative on CLL (ERIC): Board Member
FAQs
Is Prof. Yair Herishanu board-certified?
Yes, he is board-certified in internal medicine and hematology in Israel.
What types of treatments does he offer?
He offers chemotherapy, immunotherapy, targeted treatments, and CAR T-cell therapy for hematologic cancers.
Does he treat international patients?
Yes, he welcomes international patients and offers virtual consultations with multilingual support.
How long is the typical hospital stay for treatment?
It varies depending on the condition. Some treatments are outpatient, while others may require extended hospitalization.
What languages does Prof. Herishanu speak?
He speaks Hebrew and English; Russian interpretation is available during consultations.
Can I get a second opinion from him remotely?
Yes, he provides remote second opinions and pre-consultations for patients worldwide.
Does he participate in clinical trials?
Yes, he is actively involved in CLL clinical trials and research protocols at his medical center.
Patient reviews
5
Excellent
2 reviews
Detailed information
5 stars
100%
4 stars
0%
3 stars
0%
2 stars
0%
1 star
0%
Patient reviews
Russia,
Jul 11, 2024
Владимир
Доктор Яир Херишану - лечащий врач моего сына. Когда у него выявили лейкоз, мы сразу не поверили и решили с женой обследоваться в Израиле. Так попали к доктору, который подтвердил диагноз и сейчас помогает нам победить болезнь. Лечение еще в процессе, но сыну стало лучше и для нас это уже результат.
BookClinics is a trusted global medical tourism platform. Every month over 9,000 people request our assistance. Check what do we offer:
Great Choice Among 1200+ Clinics
Access to quality global healthcare with 1,000+ accredited clinics and 1,500+ certified doctors in 50 countries
BookClinics Expert Support
Get online consultations and second opinions with top world doctors, saving you time and money on travel
24/7 Complete
Guidance
Choose one or several clinics, send your medical details, get a clear cost breakdown. And only then decide where to go
No Fees
Choose one or several clinics, send your medical details, get a clear cost breakdown. And only then decide where to go
Get a Free Consultation
Choice among 1200+ clinics
BookClinics expert support
24/7 complete guidance
Choice among 1200+ clinics
BookClinics cooperates with top medical centers in 50 countries. And we can pick the best one precisely for your medical needs.
BookClinics expert support
Searching for a doctor or a clinic? The best program for your budget? We do have answers for these questions based on the experience of 920,000+ patients
24/7 complete guidance
You are never alone during your medical trip. Our team is on hand over the phone or chat to ensure you have an excellent experience.
